-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HRPB+XEYeHQ1kJ7VIB/MSbBmiJy1Kxh/zWcNnUsJ/EHVAC7xe6jq/LEGKjV/rTUq YF1bfjRqWeZKEv/U9owgVQ== 0001193125-06-116352.txt : 20060519 0001193125-06-116352.hdr.sgml : 20060519 20060519160738 ACCESSION NUMBER: 0001193125-06-116352 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060519 DATE AS OF CHANGE: 20060519 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HEMOBIOTECH INC CENTRAL INDEX KEY: 0001301348 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-81482 FILM NUMBER: 06855527 BUSINESS ADDRESS: STREET 1: 14221 DALLAS PARKWAY STREET 2: SUITE 1500 CITY: DALLAS STATE: TX ZIP: 75254 BUSINESS PHONE: 214-540-8411 MAIL ADDRESS: STREET 1: 14221 DALLAS PARKWAY STREET 2: SUITE 1500 CITY: DALLAS STATE: TX ZIP: 75254 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TEXAS TECH UNIVERSITY SYSTEM CENTRAL INDEX KEY: 0001362465 IRS NUMBER: 000000000 STATE OF INCORPORATION: TX FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1901 UNIVERSITY STREET 2: SUITE 301A CITY: LUBBOCK STATE: TX ZIP: 79404 BUSINESS PHONE: 806-742-4103 MAIL ADDRESS: STREET 1: 1901 UNIVERSITY STREET 2: SUITE 301A CITY: LUBBOCK STATE: TX ZIP: 79404 SC 13G 1 dsc13g.htm SCHEDULE 13G Schedule 13G

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

HEMOBIOTECH, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

 

 

42368P102

                                (CUSIP Number)                                

December 31, 2005

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

SEC 1745 (3-06)

Page 1 of 5 pages

CUSIP NO. 42368P102    

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

    
   

            TEXAS TECH UNIVERSITY SYSTEM

            [I.R.S. Identification No. Not Applicable]

    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*  
  (a)  ¨  
  (b)  ¨  
                Not Applicable    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                TEXAS    

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     5    SOLE VOTING POWER
 
                  814,585
    6    SHARED VOTING POWER
 
                  0
    7    SOLE DISPOSITIVE POWER
 
                  814,585
    8    SHARED DISPOSITIVE POWER
 
                  0
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                814,585    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9  
                5.8%    
12   TYPE OF REPORTING PERSON*  
                OO    

Page 2 of 5 pages

Item 1  

(a).

    Name of Issuer:      
     HEMOBIOTECH, INC.      
Item 1  

(b).

    Address of Issuer’s Principal Executive Offices:      
    

14221 DALLAS PARKWAY, SUITE 1400

DALLAS, TEXAS 75254

      
Item 2  

(a).

    Name of Person Filing:      
     TEXAS TECH UNIVERSITY SYSTEM      
Item 2  

(b).

    Address of Principal Business Office or, if None, Residence:      
    

Box 42007

1901 University, Suite 301A

Lubbock, Texas 79409-2007

      
Item 2  

(c).

    Citizenship:      
     Texas      
Item 2  

(d).

    Title of Class of Securities:      
     Common Stock      
Item 2  

(e).

    CUSIP Number:      
     42368P102      
Item 3.   If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:   
  (a)    ¨    Broker or dealer registered under Section 15 of the Exchange Act.
  (b)    ¨    Bank as defined in Section 3(a)(6) of the Exchange Act.
  (c)    ¨    Insurance company as defined in Section 3(a)(19) of the Exchange Act.
  (d)    ¨    Investment company registered under Section 8 of the Investment Company Act.
  (e)    ¨    An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
  (f)    ¨    An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
  (g)    ¨    A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
  (h)    ¨    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
  (i)    ¨    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.
  (j)    ¨    Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
  If this statement is filed pursuant to Rule 13d-1(c), check this box.  ¨      

Page 3 of 5 pages

Item 4.    Ownership      
   Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.      
   (a)    Amount beneficially owned:      
      814,585 Shares      
   (b)    Percent of class:      
      5.8%      
   (c)    Number of shares as to which such person has:      
      (i)    sole power to vote or to direct the vote:      
         814,585      
      (ii)    shared power to vote or to direct the vote:      
         0      
      (iii)    sole power to dispose or to direct the disposition of:      
         814,585      
      (iv)    shared power to dispose or to direct the disposition of:      
         0      
Item 5.    Ownership of Five Percent or Less of a Class   
   If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ¨.   
Item 6.    Ownership of More than Five Percent on Behalf of Another Person      
   Not Applicable      
Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
   Not Applicable
Item 8.    Identification and Classification of Members of the Group      
   Not Applicable      
Item 9.    Notice of Dissolution of Group      
   Not Applicable      
Item 10.    Certification      
   Not Applicable      

Page 4 of 5 pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  TEXAS TECH UNIVERSITY SYSTEM
Date: May 18, 2006   By:  

/s/ Lance Anderson

  Name:   Lance Anderson
  Title:   Managing Director, Office of Technology Transfer and Intellectual Property

Page 5 of 5 pages

-----END PRIVACY-ENHANCED MESSAGE-----